Telmisartan, ramipril, or both in patients at high risk for vascular events

Telmisartan, ramipril, or both in patients at high risk for vascular events is a topic covered in the Evidence-Based Medicine Guidelines.

To view the entire topic, please or purchase a subscription.

Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:

Evidence Central

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Telmisartan, ramipril, or both in patients at high risk for vascular events ID - 455120 BT - Evidence-Based Medicine Guidelines UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455120/all/Telmisartan__ramipril__or_both_in_patients_at_high_risk_for_vascular_events PB - Duodecim Medical Publications Limited DB - Evidence Central DP - Unbound Medicine ER -